Table 1 Clinicopathological features of 30 glioma patients and the expression of circ-MAPK4
Parameters | Group | Cases | Circ-MAPK4 expression | P-value | |||
|---|---|---|---|---|---|---|---|
| Â | Â | Â | Low | % | High | % | Â |
Gender | Male | 19 | 10 | 52.6 | 9 | 47.3 | 0.919 |
Female | 11 | 6 | 54.5 | 5 | 0.45 | ||
Age at surgery | < 30 | 9 | 6 | 66.7 | 3 | 33.3 | 0.855 |
> 30 | 21 | 10 | 47.6 | 11 | 52.3 | ||
Pathological stage | WTO:I~II | 7 | 7 | 100 | 0 | 0 | 0.044 |
WTO:III~IV | 23 | 9 | 39.1 | 14 | 60.8 | ||
Tumor size (maximum diameter in MRI) | > = 30 mm | 14 | 8 | 57.1 | 6 | 42.8 | 0.513 |
< 30 mm | 16 | 8 | 50 | 8 | 50 | ||
Tumor necrosis | Yes | 11 | 4 | 36.3 | 7 | 0.63 | 0.156 |
No | 19 | 12 | 63.1 | 7 | 36.8 | ||
Total | Â | 30 | 15 | 50 | 15 | 50 | Â |